Agarwal Arjun has filed 12 insider transactions across 1 company since January 2025.
Most recent transaction: a option exercise of 5833 shares of Oruka Therapeutics, Inc. ($ORKA) on May 18, 2026.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | Oruka Therapeutics, Inc. | $ORKA | Agarwal Arjun | Senior Vice President, Finance | M | Employee Stock Option (right to buy) | 5833 | $0.00 | 64,167.0000 | 42,095,951 | 8.33% | 0.01% |
| May 18, 2026 | Oruka Therapeutics, Inc. | $ORKA | Agarwal Arjun | Senior Vice President, Finance | S | Common Stock | 4600 | $59.19 | 17,906.0000 | 42,095,951 | 20.44% | 0.01% |
| May 18, 2026 | Oruka Therapeutics, Inc. | $ORKA | Agarwal Arjun | Senior Vice President, Finance | S | Common Stock | 800 | $60.34 | 17,106.0000 | 42,095,951 | 4.47% | 0.00% |
| May 18, 2026 | Oruka Therapeutics, Inc. | $ORKA | Agarwal Arjun | Senior Vice President, Finance | S | Common Stock | 700 | $61.16 | 16,406.0000 | 42,095,951 | 4.09% | 0.00% |
| May 18, 2026 | Oruka Therapeutics, Inc. | $ORKA | Agarwal Arjun | Senior Vice President, Finance | M | Employee Stock Option (right to buy) | 2000 | $0.00 | 118,000.0000 | 42,095,951 | 1.67% | 0.00% |
| May 18, 2026 | Oruka Therapeutics, Inc. | $ORKA | Agarwal Arjun | Senior Vice President, Finance | M | Common Stock | 2000 | $12.50 | 20,863.0000 | 42,095,951 | 10.60% | 0.00% |
| May 18, 2026 | Oruka Therapeutics, Inc. | $ORKA | Agarwal Arjun | Senior Vice President, Finance | M | Common Stock | 5833 | $34.39 | 26,696.0000 | 42,095,951 | 27.96% | 0.01% |
| May 18, 2026 | Oruka Therapeutics, Inc. | $ORKA | Agarwal Arjun | Senior Vice President, Finance | S | Common Stock | 4190 | $58.34 | 22,506.0000 | 42,095,951 | 15.70% | 0.01% |
| March 16, 2026 | Oruka Therapeutics, Inc. | $ORKA | Agarwal Arjun | Senior Vice President, Finance | S | Common Stock | 395 | $41.30 | 18,863.0000 | 42,095,951 | 2.05% | 0.00% |
| Jan. 23, 2026 | Oruka Therapeutics, Inc. | $ORKA | Agarwal Arjun | SVP, Finance | A | Common Stock | 17500 | $0.00 | 19,258.0000 | 42,095,951 | 995.45% | 0.04% |
| Jan. 23, 2026 | Oruka Therapeutics, Inc. | $ORKA | Agarwal Arjun | SVP, Finance | A | Employee Stock Option (right to buy) | 70000 | $0.00 | 70,000.0000 | 42,095,951 | 9999.99% | 0.17% |
| Jan. 22, 2025 | Oruka Therapeutics, Inc. | $ORKA | Agarwal Arjun | SVP, Finance | A | Employee Stock Option (right to buy) | 120000 | $0.00 | 120,000.0000 | 16,789,362 | 9999.99% | 0.71% |